Paclitaxel-Coated Balloon Effective for Coronary In-Stent Restenosis
MONDAY, March 11, 2024 -- A paclitaxel-coated balloon is superior to an uncoated balloon for the composite end point of target lesion failure among patients undergoing coronary angioplasty for in-stent restenosis, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2024 Category: Pharmaceuticals Source Type: news
FDA OKs First Drug-Coated Balloon for In-Stent Restenosis FDA OKs First Drug-Coated Balloon for In-Stent Restenosis
The Agent DCB, from Boston Scientific, was superior to uncoated balloon angioplasty for the treatment of coronary artery in-stent restenosis in a pivotal trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 1, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Coding changes that will impact radiology practices in 2024
Erin Stephens.The annual update to the Current Procedural Terminology1 (CPT) for 2024 has 230 new codes, 70 revised codes, and 49 deleted codes. In addition, there are 395 new diagnosis codes contained in the ICD-10-CM2 update, about one-third of them describing new ways to capture accidents and injuries. Although relatively few of these changes will impact radiology practices, it’s essential to know what they are and adjust your practice systems accordingly.
Diagnostic radiology
Coronary Fractional Flow Reserve (FFR) with CT:
New Category I code 75580 will replace Category III codes 0501T, 0502T, 0503T, and 0504T to ...
Source: AuntMinnie.com Headlines - February 12, 2024 Category: Radiology Authors: Erin Stephens Tags: Practice Management Source Type: news
Drug-Coated Balloon Better for High-Risk In-Stent Restenosis Drug-Coated Balloon Better for High-Risk In-Stent Restenosis
A drug-coated balloon beat conventional balloon angioplasty in treating high-risk patients with in-stent restenosis for outcomes of target lesion restenosis or failure, the AGENT IDE study has shown.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 3, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Drug-Coated Balloon Answers 'Embarrassing' Need for In-Stent Restenosis in U.S.
(MedPage Today) -- SAN FRANCISCO -- The Agent paclitaxel-coated balloon was better than conventional balloon angioplasty for in-stent restenosis (ISR), according to the AGENT IDE pivotal trial that will be used to support the device's case for... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 25, 2023 Category: Cardiology Source Type: news
How cardiac interventional radiographers promote better patient outcomes
Chris Schmidt.Cardiac interventional (CI) radiographers play a vital role in the diagnosis and treatment of patients during their procedure in the cardiac catheterization laboratory. They are skilled healthcare professionals who specialize in using imaging technology and minimally invasive procedures to diagnose and treat various cardiac and vascular conditions. CI radiographers work closely with radiologists, vascular surgeons, and interventional cardiologists to perform procedures such as angioplasty, stent placement, heart perfusion studies, and more. These procedures are often used to open blocked blood vessels, repair...
Source: AuntMinnie.com Headlines - October 23, 2023 Category: Radiology Tags: Radiologic Technologist Cardiovascular Radiology Interventional Radiology Source Type: news
Balloon Angioplasty Aids Chronic Thromboembolic Pulmonary Hypertension
FRIDAY, April 28, 2023 -- Balloon pulmonary angioplasty (BPA) with refined techniques can be effective for treating patients with chronic thromboembolic pulmonary hypertension (CTEPH), according to a study published online April 12 in JACC:... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 28, 2023 Category: Pharmaceuticals Source Type: news
Balloon Pulmonary Angioplasty Becoming Safer Over Time
MONDAY, April 10, 2023 -- Balloon pulmonary angioplasty (BPA) is becoming safer over time, with a reduction seen in complications from 2013-2017 to 2018-2022, according to a review published online March 22 in JACC: Cardiovascular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 10, 2023 Category: Pharmaceuticals Source Type: news
Medtronic Launches Newest Drug-Eluting Stent: The Onyx Frontier ™
The major improvement is that it employs a more deliverable system: an innovative dual-layer balloon, a lower profile for crossing, and increased catheter flexibility. These refinements point to a 16% improvement in deliverability vs. the previous generation while maintaining superior radial strength. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - August 25, 2022 Category: Cardiology Source Type: news
Paclitaxel Balloons on Par With Repeat Stenting for In-Stent CTO Paclitaxel Balloons on Par With Repeat Stenting for In-Stent CTO
The incidence of long-term adverse events, however, was high with balloon angioplasty and repeat stenting, highlighting the difficulty of treating this complex patient subset.First Look (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 8, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Medtronic Receives FDA Approval for Latest Generation Drug-Eluting Coronary Stent System
Design changes include increased catheter flexibility, an innovative dual-layer balloon technology and a lower crossing profile, leading to a 16% improvement in deliverability vs. the previous generation Resolute Onyx DES. Onyx Frontier offers a broad size matrix to treat more patients and is the only 2.0 mm DES available in the United States (similar to Resolute Onyx). Further, Onyx Frontier continues to provide 4.50-5.00 mm sizes that can be expanded to 6.00 mm - specifically designed to support extra-large vessels. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - May 13, 2022 Category: Cardiology Source Type: news
Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease
SINGAPORE, Aug. 27, 2020 -- (Healthcare Sales & Marketing Network) -- Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the FUTURE BTK trial (Randomized Controlled Trial of Fi... Devices, Interventional Concept Medical, critical limb ischemia, angioplasty, MagicTouch PTA, sirolimus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 27, 2020 Category: Pharmaceuticals Source Type: news
What Are the Main Acyanotic Congenital Heart Diseases?
Discussion
Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here.
Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also.
Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
COVID-19 Business Updates Provide Some Clarity
The unknowns still outnumber the knowns, but recent business updates provide some clarity around how the medical device industry is fairing during the COVID-19 pandemic. First and foremost, it is clear that companies are hurting in the areas of elective procedures, which are being deferred. But there may be some silver linings hidden amongst the bad news.
Needham & Co. medtech analyst Mike Matson estimates that medical device sales across the industry will continue to drop by an average of 40% to 50% until the economy begins to reopen and hospitals start to resume elective procedures.
Matson's e...
Source: MDDI - April 10, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: COVID-19 Business Source Type: news
FDA offers guidance on angioplasty and specialty catheters
The U.S. Food and Drug Administration (FDA) has issued a draft guidance for...Read more on AuntMinnie.comRelated Reading:
FDA offers guidance on coated devices
Cinematic rendering offers clinical utility in MSK CT
Coronary CTA beats stress test for changing lifestyles
Medtronic launches new endoscopic catheter
r4 Vascular gets FDA clearance for PTA balloon (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 10, 2020 Category: Radiology Source Type: news
